We serve Chemical Name:azanium,1,2,6-trifluoro-3,4,5-trifluorooxycyclohexa-2,4-diene-1-carboxylate CAS:14639-94-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:azanium,1,2,6-trifluoro-3,4,5-trifluorooxycyclohexa-2,4-diene-1-carboxylate
CAS.NO:14639-94-2
Synonyms:Triammonium hexafluorogallate
Molecular Formula:C7H5F6NO5
Molecular Weight:297.10900
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:68.23000
Exact Mass:297.00700
LogP:2.55090
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 3288
Packing Group:III
Contact us for information like Triammonium hexafluorogallate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Triammonium hexafluorogallate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Triammonium hexafluorogallate Use and application,Triammonium hexafluorogallate technical grade,usp/ep/jp grade.
Related News: We are pleased that intravenous rigosertib will be made compliantly available to suitable patients with higher-risk MDS through their physicians in designated countries. azanium,1,2,6-trifluoro-3,4,5-trifluorooxycyclohexa-2,4-diene-1-carboxylate manufacturer We are pleased that intravenous rigosertib will be made compliantly available to suitable patients with higher-risk MDS through their physicians in designated countries. azanium,1,2,6-trifluoro-3,4,5-trifluorooxycyclohexa-2,4-diene-1-carboxylate supplier At the same time, because the profits of a single variety of characteristic APIs do not have long-term growth, companies need more product reserves. azanium,1,2,6-trifluoro-3,4,5-trifluorooxycyclohexa-2,4-diene-1-carboxylate vendor We also have to consider the degree of concentration and which temperature allows a high quality of API to be manufactured efficiently. azanium,1,2,6-trifluoro-3,4,5-trifluorooxycyclohexa-2,4-diene-1-carboxylate factory We are pleased that intravenous rigosertib will be made compliantly available to suitable patients with higher-risk MDS through their physicians in designated countries.
